American International Group’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-206,358
| Closed | -$27.2K | – | 3195 |
|
|
2020
Q4 | $27.2K | Sell |
206,358
-181
| -0.1% | -$24 | 0.1% | 153 |
|
|
2020
Q3 | $9.86M | Sell |
206,539
-149
| -0.1% | -$7.12K | 0.05% | 358 |
|
|
2020
Q2 | $9.85M | Buy |
206,688
+17
| +0% | +$810 | 0.05% | 352 |
|
|
2020
Q1 | $10.1M | Sell |
206,671
-385
| -0.2% | -$18.9K | 0.06% | 277 |
|
|
2019
Q4 | $11.9M | Buy |
207,056
+68
| +0% | +$3.9K | 0.05% | 345 |
|
|
2019
Q3 | $7.45M | Sell |
206,988
-49
| -0% | -$1.76K | 0.03% | 554 |
|
|
2019
Q2 | $6.44M | Sell |
207,037
-38,325
| -16% | -$1.19M | 0.03% | 621 |
|
|
2019
Q1 | $5.75M | Buy |
245,362
+5,586
| +2% | +$131K | 0.02% | 670 |
|
|
2018
Q4 | $3.3M | Sell |
239,776
-36
| -0% | -$495 | 0.01% | 846 |
|
|
2018
Q3 | $2.39M | Buy |
+239,812
| New | +$2.39M | 0.01% | 976 |
|